These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11772285)

  • 1. Antiglucocorticoid drugs in the treatment of depression.
    Reus VI; Wolkowitz OM
    Expert Opin Investig Drugs; 2001 Oct; 10(10):1789-96. PubMed ID: 11772285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychological functioning in health and mood disorder: Modulation by glucocorticoids and their receptors.
    Gallagher P; Reid KS; Ferrier IN
    Psychoneuroendocrinology; 2009 Dec; 34 Suppl 1():S196-207. PubMed ID: 19541428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiglucocorticoid therapies in major depression: a review.
    Murphy BE
    Psychoneuroendocrinology; 1997; 22 Suppl 1():S125-32. PubMed ID: 9264159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline cortisol and the efficacy of antiglucocorticoid treatment in mood disorders: A meta-analysis.
    Lombardo G; Enache D; Gianotti L; Schatzberg AF; Young AH; Pariante CM; Mondelli V
    Psychoneuroendocrinology; 2019 Dec; 110():104420. PubMed ID: 31499391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothalamic-pituitary-adrenocortical system dysregulation and new treatment strategies in depression.
    Schüle C; Baghai TC; Eser D; Rupprecht R
    Expert Rev Neurother; 2009 Jul; 9(7):1005-19. PubMed ID: 19589050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiglucocorticoid strategies in hypercortisolemic states.
    Wolkowitz OM; Reus VI; Manfredi F; Ingbar J; Brizendine L
    Psychopharmacol Bull; 1992; 28(3):247-51. PubMed ID: 1480727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mifepristone: treatment of Cushing's syndrome.
    Sartor O; Cutler GB
    Clin Obstet Gynecol; 1996 Jun; 39(2):506-10. PubMed ID: 8734015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiglucocorticoid treatments for mood disorders.
    Gallagher P; Malik N; Newham J; Young AH; Ferrier IN; Mackin P
    Cochrane Database Syst Rev; 2008 Jan; (1):CD005168. PubMed ID: 18254070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder.
    Young AH; Gallagher P; Watson S; Del-Estal D; Owen BM; Ferrier IN
    Neuropsychopharmacology; 2004 Aug; 29(8):1538-45. PubMed ID: 15127079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.
    Laue L; Chrousos GP; Loriaux DL; Barnes K; Munson P; Nieman L; Schaison G
    J Clin Endocrinol Metab; 1988 Feb; 66(2):290-3. PubMed ID: 2828406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of antiglucocorticoid treatment on 5-HT1A function in depressed patients and healthy subjects.
    Price LH; Cappiello A; Malison RT; McDougle CJ; Pelton GH; Schöllnhammer G; Heninger GR
    Neuropsychopharmacology; 1997 Oct; 17(4):246-57. PubMed ID: 9326749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of antidepressant drugs on the hypothalamic-pituitary-adrenal axis activity and glucocorticoid receptor function.
    Budziszewska B
    Pol J Pharmacol; 2002; 54(4):343-9. PubMed ID: 12523487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of depression with antiglucocorticoid drugs.
    Wolkowitz OM; Reus VI
    Psychosom Med; 1999; 61(5):698-711. PubMed ID: 10511017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoids and cognitive function: from physiology to pathophysiology.
    Jameison K; Dinan TG
    Hum Psychopharmacol; 2001 Jun; 16(4):293-302. PubMed ID: 12404564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychiatric disorders and cognitive dysfunction in patients with Cushing's disease.
    Chen YF; Li YF; Chen X; Sun QF
    Chin Med J (Engl); 2013 Aug; 126(16):3156-60. PubMed ID: 23981629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation.
    Bertagna X; Escourolle H; Pinquier JL; Coste J; Raux-Demay MC; Perles P; Silvestre L; Luton JP; Strauch G
    J Clin Endocrinol Metab; 1994 Feb; 78(2):375-80. PubMed ID: 8106625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression-related cognitive impairment: possibilities for its pharmacological treatment.
    Mitchell AJ; Dening TR
    J Affect Disord; 1996 Jan; 36(3-4):79-87. PubMed ID: 8821310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The stress system in the human brain in depression and neurodegeneration.
    Swaab DF; Bao AM; Lucassen PJ
    Ageing Res Rev; 2005 May; 4(2):141-94. PubMed ID: 15996533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system?
    Barden N; Reul JM; Holsboer F
    Trends Neurosci; 1995 Jan; 18(1):6-11. PubMed ID: 7535490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary-adrenal response to the antiglucocorticoid action of RU 486 in Cushing's syndrome.
    Bertagna X; Bertagna C; Laudat MH; Husson JM; Girard F; Luton JP
    J Clin Endocrinol Metab; 1986 Sep; 63(3):639-43. PubMed ID: 3734034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.